Prognostic role of the ABO blood types in Chinese patients with curatively resected non-small cell lung cancer: a retrospective analysis of 1601 cases at a single cancer center
Open Access
- 28 September 2015
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Cancer
- Vol. 34 (3) , 54-82
Abstract
A positive association between the ABO blood types and survival has been suggested in several malignancies. The aim of this study was to assess the role of the ABO blood types in predicting the prognosis of Chinese patients with curatively resected non-small cell lung cancer (NSCLC). We retrospectively analyzed 1601 consecutive Chinese patients who underwent curative surgery for NSCLC between January 1, 2005 and December 31, 2009. The relationship between the ABO blood types and survival was investigated. In addition, univariate and multivariate analyses were performed. Group 1 (patients with the blood type O or B) had significantly prolonged overall survival (OS) compared with group 2 (patients with the blood type A or AB), with a median OS of 74.9 months versus 61.5 months [hazard ratio (HR) 0.83; 95% confidence interval (CI) 0.72–0.96; P = 0.015]. Additionally, group 1 had significantly longer disease-free survival (DFS; HR 0.86; 95% CI 0.76–0.98; P = 0.022) and locoregional relapse-free survival (LRFS; HR 0.79; 95% CI 0.64–0.98; P = 0.024) than group 2. The association was not significantly modified by other risk factors for NSCLC, including smoking status, pathologic tumor-node-metastasis stage, pT category, pN category, and chemotherapy. There is an association between the ABO blood types and the survival of Chinese patients with resected NSCLC. Patients with the blood type O or B had significantly prolonged OS, DFS, and LRFS compared with those with the blood type A or AB.Keywords
This publication has 38 references indexed in Scilit:
- AB0 blood group and prognosis in patients with pancreatic cancerBMC Cancer, 2012
- ABO blood group and breast cancer incidence and survivalInternational Journal of Cancer, 2011
- Higher frequency of secretor phenotype in O blood group – its benefits in prevention and/or treatment of some diseasesInternational Journal of Nanomedicine, 2010
- Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levelsHuman Molecular Genetics, 2010
- Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetesHuman Molecular Genetics, 2010
- Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancerNature Genetics, 2009
- Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 WomenPLOS Genetics, 2008
- Cancer-related inflammationNature, 2008
- A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs)PLOS Genetics, 2008
- Inflammation and cancerNature, 2002